Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein

被引:36
|
作者
Marbeuf-Gueye, C
Ettori, D
Priebe, W
Kozlowski, H
Garnier-Suillerot, A
机构
[1] Univ Paris 13, UPRES A7033, Lab Physicochim Biomol & Cellulaire, F-93017 Bobigny, France
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Wroclaw B Beirut Univ, Inst Chem, PL-50383 Wroclaw, Poland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1999年 / 1450卷 / 03期
关键词
multidrug resistance; P-glycoprotein; MRP; doxorubicin; kinetic; resistance factor;
D O I
10.1016/S0167-4889(99)00060-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multidrug resistance (MDR) in model systems is known to be conferred by two different integral proteins, the 170-kDa P-glycoprotein (Pgp) and the 190-kDa multidrug resistance associated protein (MRP1). One possible pharmacological approach to overcome drug resistance is the use of specific inhibitors, which enhance the cytotoxicity of known antineoplastic agents. However, while many compounds have been proven to be very efficient in inhibiting Pgp activity only some of them are able to inhibit MRP1. The other Likely approach is based on the design and synthesis of new non-cross-resistant drugs with physicochemical properties favoring the uptake of the drug by the resistant cells. The intracellular drug retention influences its cytotoxic effect. The level of the intracellular drug content is a function of the amount of drug transported inside the cell (influx) and the amount of drug expelled from the cell (efflux). In this work, the kinetics of drug uptake and the kinetics of active efflux of several anthracycline derivatives in both Pgp expressing K562/Adr cells and MRP1 expressing GLC4/Adr cells was determined. Our data have shown that in both cell lines there is no correlation between the resistance Factor and the kinetics of drug efflux by these pumping systems. However, a very good correlation between the resistance factor and the kinetics of drug uptake has been established in both cell lines: the resistance factor decreases when the kinetics of drug uptake increases; This work has clearly shown that when the rate of transmembrane transport of anthracycline is high enough, the efflux mediated by the protein transporter is not able to pace with it. The protein transporter essentially operates in a futile cycle and the resistance factor is tending to one. It does not mean, however, that when the resistance factor is close to one the anthracycline is not transported by the pump. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 50 条
  • [1] P-glycoprotein, multidrug resistance and protein kinase C
    Fine, RL
    Chambers, TC
    Sachs, CW
    STEM CELLS, 1996, 14 (01) : 47 - 55
  • [2] Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein
    Karthika, Chenmala
    Sureshkumar, Raman
    Zehravi, Mehrukh
    Akter, Rokeya
    Ali, Faraat
    Ramproshad, Sarker
    Mondal, Banani
    Tagde, Priti
    Ahmed, Zubair
    Khan, Farhat S.
    Rahman, Md Habibur
    Cavalu, Simona
    LIFE-BASEL, 2022, 12 (06):
  • [3] Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer
    Xu, H-W
    Xu, L.
    Hao, J-H
    Qin, C-Y
    Liu, H.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (01) : 34 - 42
  • [4] An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein
    Yang, Xiaoqian
    Li, Xiaoduan
    Duan, Zhenfeng
    Wang, Xipeng
    CURRENT CANCER DRUG TARGETS, 2018, 18 (07) : 677 - 696
  • [5] Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
    Zhou, Yuanyuan
    Chung, Po-yee
    Ma, Jessica Yuen-wuen
    Lam, Alfred King-yin
    Law, Simon
    Chan, Kwok-wah
    Chan, Albert Sun-chi
    Li, Xingshu
    Lam, Kim-hung
    Chui, Chung-hin
    Tang, Johnny Cheuk-on
    BIOLOGY-BASEL, 2019, 8 (04):
  • [6] MULTIDRUG-RESISTANCE DUE TO P-GLYCOPROTEIN
    SYMES, MO
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 3 (03) : 539 - 542
  • [7] Multidrug Resistance Through the Spectacle of P-Glycoprotein
    Goda, Katalin
    Bacso, Zsolt
    Szabo, Gabor
    CURRENT CANCER DRUG TARGETS, 2009, 9 (03) : 281 - 297
  • [8] Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells
    Chang, Ying-Tzu
    Wang, Charles C. N.
    Wang, Jiun-Yi
    Lee, Tsui-Er
    Cheng, Yung-Yi
    Morris-Natschke, Susan L.
    Lee, Kuo-Hsiung
    Hung, Chin-Chuan
    PHYTOMEDICINE, 2019, 53 : 252 - 262
  • [9] Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
    Nabekura, Tomohiro
    Yamaki, Takeshi
    Ueno, Kazuyuki
    Kitagawa, Shuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 867 - 873
  • [10] Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
    Tomohiro Nabekura
    Takeshi Yamaki
    Kazuyuki Ueno
    Shuji Kitagawa
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 867 - 873